Yahiaoui_2016_Eur.J.Med.Chem_121_283

Reference

Title : Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease - Yahiaoui_2016_Eur.J.Med.Chem_121_283
Author(s) : Yahiaoui S , Hamidouche K , Ballandonne C , Davis A , de Oliveira Santos JS , Freret T , Boulouard M , Rochais C , Dallemagne P
Ref : Eur Journal of Medicinal Chemistry , 121 :283 , 2016
Abstract : Yahiaoui_2016_Eur.J.Med.Chem_121_283
ESTHER : Yahiaoui_2016_Eur.J.Med.Chem_121_283
PubMedSearch : Yahiaoui_2016_Eur.J.Med.Chem_121_283
PubMedID: 27266998

Related information

Citations formats

Yahiaoui S, Hamidouche K, Ballandonne C, Davis A, de Oliveira Santos JS, Freret T, Boulouard M, Rochais C, Dallemagne P (2016)
Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease
Eur Journal of Medicinal Chemistry 121 :283

Yahiaoui S, Hamidouche K, Ballandonne C, Davis A, de Oliveira Santos JS, Freret T, Boulouard M, Rochais C, Dallemagne P (2016)
Eur Journal of Medicinal Chemistry 121 :283